PTS and cancer: It was demonstrated that dysregulations of the activity or expression of certain PTPs are crucially implicated in the development of serious human pathologies, including cancer, autoimmune, metabolic and cardiovascular diseases; therefore, these enzymes have received attention as novel drug targets [13,15,16,17].